Active Ingredient(s): Calcipotriene
FDA Approved: * December 29, 1993
Pharm Company: * LEO PHARM
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Dovonex Overview

Calcipotriol (INN) or calcipotriene (USAN) is a synthetic derivative of calcitriol, a form of vitamin D. It is used in the treatment of psoriasis, marketed under the trade name "Dovonex" in the United States, "Daivonex" outside of North America, and "Psorcutan" in Germany. This medication is safe for long-term application in psoriatic skin conditions. Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Pharmacology 5.1 Mechanism of action 5.2 Pharmacokinetic...

Read more Dovonex Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Dovonex Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Aerosol, Foam: 0.005%
  • Cream: 0.005%, 0.01%
  • Foam: 0.01%
  • Ointment: 0.005%, 0.01%
  • Solution: 0.005%, 0.01%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Dovonex: (6 results)

Sorted by National Drug Code
  • 0430-3020 Dovonex 50 ug/g Topical Cream by Warner Chilcott (Us), LLC
  • 0430-3030 Dovonex .05 mg/ml Topical Solution by Warner Chilcott (Us), LLC
  • 50222-260 Dovonex 50 ug/g Topical Cream by Leo Pharma Inc.
  • 50222-403 Dovonex .05 mg/ml Topical Solution by Leo Pharma Inc.
  • 54868-4725 Dovonex 50 ug/g Topical Cream by Physicians Total Care, Inc.
  • 54868-6057 Dovonex .05 mg/ml Topical Solution by Physicians Total Care, Inc.

Other drugs which contain Calcipotriene or a similar ingredient: (7 results)